Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sangamo Therapeutics (NQ: SGMO )

11.99 USD UNCHANGED
Streaming Delayed Price Updated: 7:56 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.99
Bid (Size) 11.32 (1)
Ask (Size) 12.20 (15)
Prev. Close 11.99
Today's Range 11.99 - 11.99
52wk Range 4.810 - 19.43
Shares Outstanding 101,494,606
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported fourth quarter and full year 2020 financial results and recent business highlights. 
From Business Wire News Releases
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
February 18, 2021
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: 
From Business Wire News Releases

Performance

YTD
-24.69%
-24.69%
1 Month
-14.84%
-14.84%
3 Month
+20.02%
+20.02%
6 Month
+8.70%
+8.70%
1 Year
+41.06%
+41.06%

More News

Read More
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2020 Conference Call and Webcast
February 17, 2021
From Business Wire News Releases
Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer
February 01, 2021
From Business Wire News Releases
Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee
January 06, 2021
From Business Wire News Releases
Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From Business Wire News Releases
Analysts Expect PBE Will Reach $85
February 23, 2021
Tags ETFs
From ETF Channel
Sangamo Therapeutics Inc (SGMO) Q4 2020 Earnings Call Transcript
February 25, 2021
Tags Market News SGMO
From Motley Fool
7 CRISPR Stocks for the Future of Medicine
January 15, 2021
Tags NTLA CLLS Market News
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 22, 2020
Tags Intraday Update SGMO Market News
From Benzinga
Sangamo Therapeutics Scores Relative Strength Rating Upgrade
December 23, 2020
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media